RPS-21683-01317
2 vaccinations
1 coded response
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 430 / OH
- Registered
- 2022-11-02
- Relationship
- Child or adolescent in my care
- Guardian
- LNW-11132-83668
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-29
Dose 1 — ModernaCo-administered: Flu
-
2022-11-02
Registered in v-safe
- 2022-11-02
-
2022-11-07
Health check-in — day 7, dose 1, under 3Feeling: Fair · Fever · Irritability/cryingUnder 3 check-in
- 2022-11-12
- 2022-11-26
-
2022-11-29
Dose 2 — Moderna
-
2022-12-03
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Rash, not including the immediate area around the injection siteUnder 3 check-in
- 2022-12-05
- 2022-12-06
- 2022-12-13
- 2022-12-20
- 2022-12-27
-
2023-01-05
Survey response — day 35, dose 2, under 3MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
- 2023-01-10
- 2023-05-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-29 | Moderna | Flu |
| 2 | 2022-11-29 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release